Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mayo Clinic CEO John Noseworthy says his company's investments in genome research, stem cells and regenerative medicine, and new, cheaper ways to deliver quality care, will transform the future of patient care.

  • untitled
In this ongoing interview series, FORTUNE senior editor-at-large Geoff Colvin examines the biggest challenges in business through conversations with top executives at the heart of those issues.
@geoffcolvin